Jorge A. Ortega

2.4k total citations
25 papers, 1.6k citations indexed

About

Jorge A. Ortega is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Jorge A. Ortega has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 5 papers in Oncology. Recurrent topics in Jorge A. Ortega's work include Sarcoma Diagnosis and Treatment (5 papers), Testicular diseases and treatments (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Jorge A. Ortega is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), Testicular diseases and treatments (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Jorge A. Ortega collaborates with scholars based in United States, Spain and Switzerland. Jorge A. Ortega's co-authors include G. Denman Hammond, John J. Quinn, Mark Krailo, James H. Feusner, Denis R. King, Joel E. Haas, Audrey E. Evans, R. D. T. Jenkin, Chu H. Chang and Simon Krämer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Genetics.

In The Last Decade

Jorge A. Ortega

25 papers receiving 1.6k citations

Peers

Jorge A. Ortega
Vita J. Land United States
J. Plaschkes Switzerland
Lea F. Surrey United States
Carl Lenarsky United States
Vita J. Land United States
Jorge A. Ortega
Citations per year, relative to Jorge A. Ortega Jorge A. Ortega (= 1×) peers Vita J. Land

Countries citing papers authored by Jorge A. Ortega

Since Specialization
Citations

This map shows the geographic impact of Jorge A. Ortega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge A. Ortega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge A. Ortega more than expected).

Fields of papers citing papers by Jorge A. Ortega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge A. Ortega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge A. Ortega. The network helps show where Jorge A. Ortega may publish in the future.

Co-authorship network of co-authors of Jorge A. Ortega

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge A. Ortega. A scholar is included among the top collaborators of Jorge A. Ortega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge A. Ortega. Jorge A. Ortega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ortega, Jorge A., Juan Mauricio Pardo Oviedo, A. Tríbulo, et al.. (2018). 196 Embryo production using follicle-stimulating hormone (FSH) or FSH + equine chorionic gonadotropin in beef donors. Reproduction Fertility and Development. 31(1). 223–223. 2 indexed citations
2.
Malogolowkin, Marcio H., Howard M. Katzenstein, Mark Krailo, et al.. (2008). Redefining the Role of Doxorubicin for the Treatment of Children With Hepatoblastoma. Journal of Clinical Oncology. 26(14). 2379–2383. 45 indexed citations
3.
Blasco, A., Jorge A. Ortega, Á. Climent, & M. A. Santacreu. (2005). Divergent selection for uterine capacity in rabbits. I. Genetic parameters and response to selection1. Journal of Animal Science. 83(10). 2297–2302. 22 indexed citations
4.
Katzenstein, Howard M., Mark Krailo, Marcio H. Malogolowkin, et al.. (2003). Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer. 97(8). 2006–2012. 112 indexed citations
5.
Raney, R. Beverly, Jane L. Meza, James R. Anderson, et al.. (2001). Treatment of children and adolescents with localized parameningeal sarcoma: Experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS‐II through ‐IV, 1978–1997*†. Medical and Pediatric Oncology. 38(1). 22–32. 81 indexed citations
7.
Ortega, Jorge A., et al.. (2000). Presence of Well-Differentiated Rhabdomyoblasts at the End of Therapy for Pelvic Rhabdomyosarcoma: Implications for the Outcome. ˜The œAmerican journal of pediatric hematology/oncology. 22(2). 106–111. 25 indexed citations
8.
Tornout, Jan M. Van, Jonathan D. Buckley, John J. Quinn, et al.. (1997). Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.. Journal of Clinical Oncology. 15(3). 1190–1197. 76 indexed citations
9.
Chiara, Annarosaria De, Jan M. Van Tornout, Yoichi Hachitanda, Jorge A. Ortega, & Hiroyuki Shimada. (1992). Melanotic Neuroectodermal Tumor of Infancy A Case Report of Paratesticular Primary with Lymph Node Involvement. Journal of Pediatric Hematology/Oncology. 14(4). 356–360. 14 indexed citations
10.
Ortega, Jorge A., Mark Krailo, Joel E. Haas, et al.. (1991). Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group.. Journal of Clinical Oncology. 9(12). 2167–2176. 139 indexed citations
11.
Sklar, Charles A., L. L. Robison, M E Nesbit, et al.. (1990). Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Study Group.. Journal of Clinical Oncology. 8(12). 1981–1987. 89 indexed citations
12.
Özkaynak, M. Fevzi, Jorge A. Ortega, Walter E. Laug, Vicente Gilsanz, & Hart Isaacs. (1990). Role of chemotherapy in pediatric pulmonary blastoma. Medical and Pediatric Oncology. 18(1). 53–56. 25 indexed citations
13.
Evans, Audrey E., R. D. T. Jenkin, Richard Sposto, et al.. (1990). The treatment of medulloblastoma. Journal of neurosurgery. 72(4). 572–582. 438 indexed citations
14.
Hamre, Merlın, L. L. Robison, M E Nesbit, et al.. (1987). Effects of radiation on ovarian function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.. Journal of Clinical Oncology. 5(11). 1759–1765. 64 indexed citations
15.
Ortega, Jorge A., et al.. (1987). ADRIAMYCIN CONTINUOUS I.V. INFUSION-HYPERFRACTIONATED RADIATION THERAPY FOR THE TREATMENT OF RECURRENT PEDIATRIC SOLID TUMORS. Pediatric Research. 21(4). 303A–303A. 1 indexed citations
16.
Ruymann, Frederick B., Mohan Beltangady, William A. Newton, et al.. (1987). INTRACRANIAL EXTENSION IN NON-PARAMENINGEAL HEAD AND NECK RHABDOMYOSARCOMA. A REPORT FROM THE INTERGROUP RHABDOMYOSARCOMA STUDY (IRS). Pediatric Research. 21(4). 305A–305A. 1 indexed citations
17.
Atkinson, James B., G. Hossein Mahour, Hart Isaacs, & Jorge A. Ortega. (1984). Hemangiopericytoma in infants and children. The American Journal of Surgery. 148(3). 372–374. 48 indexed citations
18.
DeClerck, Yves A., et al.. (1979). A fatal case of inappropriate adh secretion induced by cyclophosphamide therapy. Cancer. 44(3). 896–898. 50 indexed citations
19.
Ortega, Jorge A., Mohammed Malekzadeh, Peter P. Dukes, et al.. (1979). A Beneficial Effect of the <i>in situ </i>Kidney on <i>in vitro </i>Marrow Erythropoiesis in Chronic Renal Failure. Nephron. 23(4). 169–173. 3 indexed citations
20.
Ortega, Jorge A., Mohammed Malekzadeh, Peter P. Dukes, et al.. (1977). Exceptionally high serum erythropoietin activity in an anephric patient with severe anemia. American Journal of Hematology. 2(3). 299–306. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026